|4Apr 16, 4:15 PM ET

Bellete Ambaw 4

4 · CG Oncology, Inc. · Filed Apr 16, 2025

Insider Transaction Report

Form 4
Period: 2025-04-15
Bellete Ambaw
President and COO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-04-15+284,816284,816 total
    Exercise: $20.11Exp: 2035-04-14Common Stock (284,816 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4